Stellest vs. Atropine Eye Drops
What Stellest and Atropine Are
Stellest lenses are specialty eyeglass lenses with a unique optical design that helps slow the lengthening of your child's eye. The center of each lens provides clear distance vision, while hundreds of small lenslets in a ring around the central clear zone create specific signals that discourage the eye from growing too long. Your child wears them just like regular glasses during all waking hours.
Because Stellest lenses correct vision and control myopia at the same time, there is no separate step or routine beyond wearing glasses as usual. The technology is built into the lens itself, so the treatment happens automatically while your child goes about their day.
Low-dose atropine drops affect muscarinic receptors in the eye and are thought to influence biochemical pathways involved in eye growth; the exact mechanism is still being studied. Our eye doctor prescribes a very dilute concentration, commonly 0.01%, 0.025%, or 0.05%, selected based on age, rate of progression, and side effects. This is much weaker than the atropine used for other eye conditions. Your child uses one drop in each eye once daily, usually at bedtime.
Studies show that these low concentrations slow myopia progression with fewer side effects than higher doses. The clinical results support the use of low-dose atropine as a standard myopia control option.
Slowing myopia progression during childhood reduces the final prescription your child will have as an adult. Lower levels of nearsightedness mean a smaller risk of serious eye problems later in life, including retinal detachment, glaucoma, and myopic maculopathy (degenerative retinal changes in high myopia). Even reducing myopia by one or two diopters (D, the unit of glasses prescription) can make a meaningful difference in long-term eye health.
- High myopia increases the risk of retinal tears and detachment
- Moderate to high myopia raises the chance of early cataracts
- Severe nearsightedness can lead to vision-threatening macular changes
- Slowing progression now protects vision quality decades from now
Children often do not notice gradual vision changes, so regular eye exams are essential. Between visits, watch for your child squinting to see the board at school, sitting closer to the television, or complaining of headaches at the end of the day. Frequent requests to update glasses or a prescription that increases by more than half a diopter per year also suggests faster progression.
If you notice any of these signs, schedule an appointment so we can measure your child's prescription and eye length. Early intervention gives myopia control treatments the best chance to work effectively.
Who Should Consider Each Treatment
Stellest lenses are often started in early school-age years through early teens, depending on progression, though we may prescribe them for younger or older children based on individual needs. Your child should have myopia, often mild myopia and above, especially with documented progression over time. The lenses work best when started early in the course of myopia development.
Because Stellest requires your child to wear glasses full-time, it is ideal for kids who already prefer glasses over contact lenses or who are too young for contact lens wear. Cooperation with wearing glasses consistently is important for success.
Low-dose atropine can be prescribed for children as young as five and may be used through the teen years. There is no strict prescription minimum, and we may start atropine even with mild myopia if progression is documented. The treatment is especially useful for younger children who may not be ready for contact lenses, or for those who want myopia control that does not depend on a specific daytime lens design. Atropine does not correct blurry distance vision, so your child still needs appropriate glasses or contact lenses for clear sight.
Atropine works independently of what your child wears for vision correction, so it can be combined with regular glasses, contact lenses, or even orthokeratology lenses. This flexibility makes it a good choice for many families.
If your child is active in sports or prefers not to wear glasses, atropine may be the better fit because it does not depend on wearing a specific lens during the day. On the other hand, if your child already wears glasses all day and dislikes eye drops, Stellest offers myopia control without adding a new daily task. Consider your family's routine and your child's preferences when choosing.
- Stellest requires consistent full-time glasses wear but no daily medication
- Atropine demands a nightly drop routine but allows any type of vision correction
- Children who play contact sports may prefer atropine with contact lenses
- Families who want a single solution may choose Stellest for simplicity
Certain eye conditions may make one treatment safer or more effective than the other. If your child has a history of allergic conjunctivitis or sensitive eyes, atropine drops might cause irritation, and Stellest lenses could be a better option. Atropine should be avoided in children with known hypersensitivity to atropine or anticholinergic medications, and we screen for angle status as part of the safety evaluation, even though acute angle closure is rare in children. Conversely, if your child has an unusual glasses prescription or significant astigmatism, we may need to evaluate whether Stellest lenses will provide clear vision.
We will review your child's full medical and eye health history before recommending a treatment. Conditions like amblyopia, strabismus, or prior eye surgery may influence which approach is safest and most likely to succeed.
Stellest and atropine are two of several myopia control approaches available. Other options include multifocal soft contact lenses, which use specialized optical zones to slow progression while correcting vision during the day. Orthokeratology involves wearing rigid lenses overnight to reshape the cornea temporarily, so your child can see clearly during the day without glasses or contact lenses. These lens-based options may be appropriate depending on age, lifestyle, and comfort with contact lens care.
In addition to optical and pharmaceutical treatments, lifestyle measures can support myopia control. Encouraging more outdoor time and taking breaks during prolonged near work may help reduce progression risk. We can discuss all available options and help you choose the best combination for your child.
Effectiveness: What the Research Shows
Clinical studies show that Stellest lenses slow myopia progression by an average of approximately 60% compared to standard single-vision glasses over two years, though outcomes depend on full-time wear, age, and individual response. This means that if your child's prescription would typically worsen by one diopter per year without treatment, Stellest might reduce that increase to about 0.4 diopters per year. Results vary from child to child, and some children respond better than others.
The lenses also reduce the rate of axial elongation by a similar percentage. Slowing eye growth is important because axial length is directly linked to the risk of future complications from high myopia.
Low-dose atropine at 0.01% concentration reduces myopia progression by approximately 30% to 50% over one to two years, depending on the study. The 0.01% dose may have smaller effects on axial length for some children, and higher concentrations such as 0.025% or 0.05% may offer greater control when progression is faster, though side effects can increase. The balance between effectiveness and comfort guides our choice of dose.
Current research supports using the lowest effective dose to maintain daily comfort while still achieving meaningful myopia control. We will monitor your child's response and adjust the concentration if needed.
Direct head-to-head studies comparing Stellest and atropine are limited, so we look at separate trials to estimate relative effectiveness. Stellest lenses tend to show slightly higher average reductions in progression and eye growth compared to low-dose atropine, though both treatments offer substantial benefit. Individual response varies widely, so the most effective choice for your child may not match the average result.
- Stellest shows around 60% reduction in progression in published trials
- Low-dose atropine shows around 30% to 50% reduction depending on concentration
- Combining both treatments may offer additional benefit in some cases
- Real-world results depend on compliance and individual biology
Myopia control slows progression but does not stop it completely or reverse existing nearsightedness. Your child will still need vision correction, and the prescription may continue to increase, just at a slower rate. The goal is to keep the final prescription as low as possible to protect long-term eye health.
We typically see the most benefit when treatment starts early and continues consistently through the years of rapid eye growth. If your child begins treatment later or uses it inconsistently, the results may be less dramatic but still worthwhile.
Side Effects and Safety Considerations
Most children adapt to Stellest lenses within a few days to a week. Some notice a slight blur or distortion in their peripheral vision at first, but this usually fades as the brain adjusts. The lenses are safe for daily wear and do not harm the eyes, though your child may need a short adjustment period to feel completely comfortable.
If your child experiences persistent headaches, dizziness, or difficulty seeing clearly through the lenses after a week, contact our office. We can check the fit and prescription to ensure everything is correct.
Low-dose atropine at 0.01% typically causes minimal side effects, but some children notice slightly larger pupils or mild sensitivity to bright light. Near vision can be affected at higher doses, making it harder to read or do close work, but the very low concentrations we use rarely cause significant reading problems. If light sensitivity is bothersome, sunglasses outdoors can help.
- Mild pupil dilation that usually does not interfere with daily activities
- Occasional light sensitivity, especially in bright sunlight
- Rare cases of stinging or redness right after drop instillation
- Near vision blur is uncommon with 0.01% but may occur at higher doses
For Stellest, encourage your child to wear the lenses full-time so the eyes adapt quickly. Taking breaks or switching back to old glasses prolongs the adjustment period. For atropine, applying drops at bedtime minimizes daytime light sensitivity, and using sunglasses outdoors manages any remaining discomfort. If side effects persist or worsen, we can adjust the treatment plan.
Both treatments are generally safe and well tolerated when properly prescribed and monitored by your eye care provider. Serious complications are rare, and most side effects are mild and manageable with simple strategies.
Seek prompt care if your child develops sudden vision loss, severe eye pain, flashes of light, or a curtain-like shadow in the vision while using either treatment. These symptoms are not typical side effects and may indicate a separate urgent eye problem. Also seek urgent evaluation for severe headache with nausea or vomiting, or halos around lights, though these are rare. Contact us right away if atropine drops cause severe redness, swelling, or an allergic reaction such as hives or difficulty breathing.
While these warning signs are very uncommon, knowing what to watch for helps ensure your child stays safe throughout treatment. When in doubt, reach out to our office or seek emergency care.
Daily Use and Practical Factors
Your child should wear Stellest glasses during all waking hours for the best myopia control effect. Clean the lenses daily with a microfiber cloth and lens cleaner to keep vision clear and prevent scratches. Store the glasses in a protective case when not in use, and bring them to every follow-up visit so we can check the fit and condition.
Because children can be active and rough on glasses, consider a durable frame and discuss lens warranties or insurance options that cover accidental damage. Keeping a backup pair of regular glasses can be helpful in case of breakage.
Give one drop in each eye once daily, preferably at bedtime. Wash your hands before handling the bottle, tilt your child's head back, and gently pull down the lower eyelid to create a small pocket for the drop. After instilling the drop, have your child close their eyes and gently press on the inner corner of the eyelid for one to two minutes to reduce systemic absorption. Do not skip doses, as consistent use is key for effective myopia control.
- Administer the drop at the same time each evening to build a routine
- If your child wears contact lenses, remove them before instilling drops and follow your prescriber's guidance on when to reinsert
- If a dose is missed, do not double the next dose; simply resume the regular schedule
- Keep the bottle out of reach of young children; do not touch the dropper tip to the eye or any surface to avoid contamination
- Discard and replace the bottle at expiration or if contamination is suspected; store as your pharmacist directs
Consistency is the biggest factor in myopia control success. For Stellest, make wearing glasses a non-negotiable part of the morning routine, just like brushing teeth. For atropine, pair the drop with bedtime rituals so it becomes automatic. Praise your child for remembering their treatment, and involve them in tracking progress at eye exams so they understand the purpose.
If your child resists, talk openly about why myopia control matters for their future vision and independence. Older children often respond well to understanding the long-term benefits, while younger kids may need rewards or visual charts to stay motivated.
Stellest lenses typically cost more upfront than standard glasses because of the specialized optics, and insurance may cover only part of the expense. Low-dose atropine is compounded by a pharmacy and billed as a prescription medication, so coverage depends on your pharmacy benefits. Both treatments represent a long-term investment, as myopia control usually continues for several years.
Ask our office for a cost estimate and check with your insurance carrier before starting treatment. Some plans cover myopia control as preventive care, while others consider it elective. Flexible spending or health savings accounts may help offset out-of-pocket costs.
Testing, Monitoring, and Follow-Up
Before beginning Stellest or atropine, we measure your child's current prescription using cycloplegic refraction to ensure accuracy, assess binocular vision and accommodative function, measure axial length (front-to-back eye length), and review family history and lifestyle factors. We may measure corneal curvature when it helps guide lens options, especially for contact lenses or orthokeratology. We also check overall eye health with a dilated exam to rule out other conditions. These baseline values help us track how well the treatment slows progression over time.
Axial length measurement is one of the most accurate ways to monitor myopia control because it shows actual eye growth. We use a specialized instrument that takes just a few seconds and does not touch the eye, making it comfortable even for young children.
At each follow-up visit, we repeat the prescription check and axial length measurement to see how much the eye has grown since the last visit. We compare these changes to typical progression rates for children not using myopia control. If your child's eye is growing more slowly than expected without treatment, we know the therapy is working.
- Monitor changes in eyeglass prescription at every visit
- Measure axial length to assess eye growth directly
- Review any side effects or challenges with the treatment
- Adjust the plan if progression is faster than expected
We usually schedule follow-up exams every six months for both Stellest and atropine to monitor progress and update prescriptions as needed. For atropine, an earlier visit or check-in may be scheduled to confirm tolerability and adherence. If your child is very young, experiencing side effects, or showing rapid progression, we may see them more often. Regular visits ensure we catch any issues early and adjust treatment to keep it safe and effective.
Consistent monitoring also allows us to celebrate progress with your family and reinforce the importance of continuing treatment through the years of active eye growth.
If myopia continues progressing quickly despite one treatment, we may suggest switching to the other option or combining Stellest and atropine for stronger control. Some studies suggest that using both together can provide added benefit for some children, especially those with aggressive progression or high myopia, though evidence varies by protocol and patient factors. We will discuss the risks and benefits of combination therapy if it becomes appropriate for your child.
Switching treatments is also an option if side effects are intolerable or if lifestyle changes make one approach more practical than the other. Our goal is to find a sustainable plan that fits your family and protects your child's vision long-term.
Frequently Asked Questions
Yes, combining both treatments can be appropriate under close supervision and may offer greater myopia control than either alone. We sometimes recommend this approach for children with rapid progression or when one treatment alone does not slow the myopia enough. The two work through different mechanisms, so they can complement each other. Side effects and benefit should be monitored, and not every child needs combination therapy.
Most children use myopia control through their early teen years, when eye growth typically slows and stabilizes. The exact duration depends on your child's age at the start of treatment and how long their prescription keeps changing. We will monitor progression yearly and discuss tapering or stopping treatment once growth plateaus.
Myopia may resume progressing at its natural rate once treatment stops, especially if your child is still young and growing. With Stellest, there is no known rebound effect, and progression typically returns to baseline age-expected rates. With atropine, stopping abruptly may cause rebound acceleration in some children, especially at higher doses, so we often taper the concentration rather than stopping suddenly. Any benefit gained during treatment is generally preserved, though the eye may continue growing after treatment ends. Stopping is safe when done appropriately, but restarting may be worthwhile if progression picks up again.
Both Stellest and atropine begin working shortly after starting treatment, but neither delivers instant results. We measure effectiveness over months to years by tracking prescription changes and eye growth. Stellest may show slightly faster measurable slowing in some studies, but individual response varies, and the difference is not dramatic enough to choose one based on speed alone.
No, myopia control slows progression but does not cure nearsightedness or eliminate the need for vision correction. Your child will still need glasses or contact lenses for clear distance vision. The benefit is a lower final prescription with reduced risk of serious eye disease as an adult, which can preserve vision quality and independence for decades.
Getting Help for Stellest vs. Atropine Eye Drops
If your child's nearsightedness is worsening each year, schedule a comprehensive eye exam to discuss whether Stellest lenses, atropine drops, or another myopia control option is right for your family. We will measure your child's eyes, review lifestyle factors, and help you choose a treatment that fits your goals and daily routine while protecting long-term vision health.